Skip to main content
Retour
Watch Compare

MapLight Therapeutics, Inc.

Qualité des données : 83%
MPLT
Nasdaq Manufacturing Chemicals
26,73 €
▼ 2,68 € (-9,11%)
Cap. Boursière: 1,31 B
Prix
28,77 €
Cap. Boursière
1,31 B
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -138,61 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-35,16%
Au-dessus de la moyenne du secteur (-53,53%)
ROIC-28,83%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio13,22
Interest CoverageN/A

Valorisation

PE (TTM)
-8,10
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -8,1 -1,5
P/B — 1,6
ROE % -35,2 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

6 analystes
Buy
Actuel
26,73 €
+22.2%
Objectif
32,67 €
28,00 €
33,00 €
37,00 €
Prévisions
P/E Prévisionnel -7,15
BPA Prévisionnel -3,74 €
CA Est. 0,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -3,74 €
-4,17 € – -3,25 €
 0,0 3
FY2026 -4,61 €
-5,75 € – -3,45 €
 0,0 3

Surprises de Résultats

Derniers 2 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,83 € -2,47 € -197,6%
Q32025 -1,73 € -37,18 € -2055,4%

ETFs Holding This Stock

IRSIX IRSIX
0,01% weight
IIRSX IIRSX
0,01% weight
IRCIX IRCIX
0,01% weight
VVICX VVICX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -161,15 M
ROE -35,16% ROA -33,61%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -138,61 M
ROIC -28,83% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 13,22
Interest Coverage N/A Asset Turnover N/A
Working Capital 226,74 M Tangible Book Value -274,18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8,10 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10,62%
Market Cap 1,31 B Enterprise Value 1,24 B
Per Share
EPS (Diluted TTM) -18,56 Revenue / Share N/A
FCF / Share -3,05 OCF / Share -3,04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86,01%
SBC-Adj. FCF -174,62 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue —
Net Income -161,15 M
EPS (Diluted) -18,56
Gross Profit —
Operating Income -169,08 M
EBITDA —
R&D Expenses 138,35 M
SG&A Expenses —
D&A —
Interest Expense —
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 479,51 M
Total Liabilities 21,14 M
Shareholders' Equity 458,37 M
Total Debt —
Cash & Equivalents 46,73 M
Current Assets 324,67 M
Current Liabilities 16,23 M